NOVEL MEMBRANE-BASED PORTABLE OXYGEN CONCENTRATOR

Information

  • Research Project
  • 2232020
  • ApplicationId
    2232020
  • Core Project Number
    R43HL053885
  • Full Project Number
    1R43HL053885-01A1
  • Serial Number
    53885
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/1/1995 - 29 years ago
  • Project End Date
    4/30/1996 - 28 years ago
  • Program Officer Name
  • Budget Start Date
    9/1/1995 - 29 years ago
  • Budget End Date
    4/30/1996 - 28 years ago
  • Fiscal Year
    1995
  • Support Year
    1
  • Suffix
    A1
  • Award Notice Date
    8/14/1995 - 29 years ago
Organizations

NOVEL MEMBRANE-BASED PORTABLE OXYGEN CONCENTRATOR

Oxygen concentrators account for the largest share of the home oxygen- delivery market, but have drawbacks that limit patients' quality of life. These drawbacks include lack of portability, reliance on a humidification system, and excessive noise. Membrane technology has shown promise as an alternative, but little progress has been made in developing an acceptable membrane system, due to limitations in current membrane performance. The goal of this program is to develop a novel membrane-based portable oxygen concentrator that overcomes the drawbacks discussed above. This technology is based on two innovations: 1) a novel membrane that combines extraordinarily high oxygen permeability with acceptable O2/N2 selectivity, and 2) a two-stage system design that reduces system size, weight, and cost. In Phase I, we propose to 1) synthesize copolymers for use in membrane fabrication, 2) fabricate and test small flat sheet membranes, 3) optimize the two-stage portable system design, and 4) design a Phase II development plan. In Phase II, we plan to design, construct, and test a membrane- based portable oxygen concentrator that meets cost and performance targets. Throughout this program, we will work with our Phase III collaborator. PROPOSED COMMERCIAL APPLICATION: The proposed technology should offer major advantages over competing devices for home medical-oxygen delivery in terms of size, weight, noise, and simplicity. The membrane developed for this application should also be appropriate for other medical applications, as well as for military and commercial uses for oxygen- enriched air (e.g., producing oxygen-enriched air during flights for the military).

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R43
  • Administering IC
    HL
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    838
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    ZRG7
  • Study Section Name
  • Organization Name
    BEND RESEARCH, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    BEND
  • Organization State
    OR
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    977018583
  • Organization District
    UNITED STATES